Hypophosphatasia

United States Hypophosphatasia Molecular Research Center

Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa

The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia

Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa

Natural History Study of Patients With Hypophosphatasia (HPP)

Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP

A Prospective Sub-Study of the Global Hypophosphatasia Registry

Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia

Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Early Check: Expanded Screening in Newborns

Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia

Characteristics of Hypophosphatasia in Adult Patients in Rheumatology and Their Value in Developing an Algorithm to HPP-diagnosis - the COHIR Multi-center Study

Study of ALXN1850 in Participants With Hypophosphatasia (HPP)

Patient Reported Outcomes in Adults With Pediatric-onset Hypophosphatasia Treated With Strensiq® (Asfotase Alfa)

Characteristics of Hypophosphatasia in Adult Patients in Rheumatology

Characterisation of Adult-Onset Hypophosphatasia

Safety and Efficacy Study of ENB-0040 in Juvenile Patients With Hypophosphatasia (HPP)

Circulating miRNAs and Bone Microstructure in Adults With Hypophosphatasia

The PORTRAIT Study